PARTNER WITH US
We are actively looking for collaboration with academics, commercial R&D-companies and other commercial parties to further develop our business. We are also looking for possibilities to help governments, institutions and NGOs strengthen societies for better pandemic preparedness and prevention.
Collaboration
Pandemblock welcomes partnerships with pharmaceutical and biotech companies interested in developing and commercializing novel antiviral nasal sprays based on sherpabody-technology. Different types of collaborations, including strategic partnerships as well as co-funded or contracted research are welcomed.
Licencing
Pandemblock is open for out-licencing of Covidin, an intranasal prophylactic and early therapeutic candidate against SARS-CoV-2, to expedite its product development as well as entry into the clinic and to the market.
Investors
We looking for dedicated investors to expand and speed our growth and product development.